• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哪些患者报告结局(PROs)和患者报告结局测量(PROMs)被研究者选择用于压力性尿失禁手术试验?- 一项系统评价。

Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials? - a systematic review.

机构信息

Department of Obstetrics and Gynaecology, Epsom and St Helier University Hospitals NHS Trust, Dorking Road, London, UK.

St George's University of London, London, UK.

出版信息

Int Urogynecol J. 2022 Nov;33(11):2941-2949. doi: 10.1007/s00192-022-05123-7. Epub 2022 Mar 7.

DOI:10.1007/s00192-022-05123-7
PMID:35254471
Abstract

INTRODUCTION AND HYPOTHESIS

The mesh controversy has highlighted the need for robust evidence of treatment safety and efficacy, particularly in the surgical treatment of stress urinary incontinence (SUI). Current trials demonstrate heterogeneity in outcomes reported as well as outcome measures used, restricting the ability to synthesize data and produce robust research evidence (Doumouchtsis et al. 5). Patient-reported outcomes (PROs) should be a focus when evaluating SUI surgery given the quality-of-life nature of this condition affecting 25-45% women worldwide (Milsom and Gyhagen 1). As part of the first step in developing a core outcome set (COS) and measures set (COMS), we aimed to systematically review RCTs evaluating SUI surgery and extract PROs and outcome measures (PROMs) used.

MATERIALS AND METHODS

We searched databases including MEDLINE and Cochrane for RCTs evaluating SUI surgical treatments from inception to January 2020. Eligibility criteria included English language and female-only subjects. PROs and PROMs were extracted and grouped into a structured inventory. PROMs were assigned to domains based on predominant theme.

RESULTS

Of 123 eligible RCTs, 116 (94%) included PROs. Forty-four different PROMs were utilized; most frequent was Patient Global Impression of Improvement (PGI-I). Fifteen PROMs were used once. The top five PROMs have evidence of validity and are highly recommended.

CONCLUSIONS

There is no consensus amongst relevant stakeholders regarding PROs or PROMs used in SUI surgery research. We propose that this consensus is required to standardize measurements and reporting and promote use of validated and reliable outcome measures. This systematic review forms the first step in the development process.

摘要

简介和假设

网片争议突出表明需要有强有力的治疗安全性和疗效证据,特别是在治疗压力性尿失禁(SUI)的手术治疗方面。目前的试验表明,报告的结果和使用的结果测量方法存在异质性,限制了综合数据和产生强有力的研究证据的能力(Doumouchtsis 等人,5)。鉴于影响全球 25-45%女性的这种对生活质量有影响的疾病,患者报告的结局(PROs)在评估 SUI 手术时应该是重点(Milsom 和 Gyhagen,1)。作为制定核心结局集(COS)和措施集(COMS)的第一步的一部分,我们旨在系统地回顾评估 SUI 手术的 RCT,并提取使用的 PRO 和结局测量(PROM)。

材料和方法

我们检索了包括 MEDLINE 和 Cochrane 在内的数据库,以获取从成立到 2020 年 1 月评估 SUI 手术治疗的 RCT。纳入标准包括英语语言和仅女性受试者。提取 PRO 和 PROM 并将其分组到一个结构化清单中。根据主要主题将 PROM 分配到各个领域。

结果

在 123 项合格的 RCT 中,有 116 项(94%)包含 PRO。使用了 44 种不同的 PROM;最常用的是患者总体印象改善(PGI-I)。有 15 种 PROM 仅使用过一次。前五种 PROM 具有有效性证据,强烈推荐使用。

结论

在 SUI 手术研究中,利益相关者之间对于 PRO 或 PROM 没有达成共识。我们建议需要达成这种共识,以标准化测量和报告,并促进使用经过验证和可靠的结局测量。这项系统综述是制定过程的第一步。

相似文献

1
Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials? - a systematic review.哪些患者报告结局(PROs)和患者报告结局测量(PROMs)被研究者选择用于压力性尿失禁手术试验?- 一项系统评价。
Int Urogynecol J. 2022 Nov;33(11):2941-2949. doi: 10.1007/s00192-022-05123-7. Epub 2022 Mar 7.
2
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.针对患有或未患有压力性尿失禁的盆腔器官脱垂女性的手术。
Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013108. doi: 10.1002/14651858.CD013108.
3
Patient-reported outcome measures for pain in women with pelvic floor disorders: a systematic review.女性盆底功能障碍性疾病疼痛的患者报告结局测量指标:系统评价。
Int Urogynecol J. 2022 Sep;33(9):2325-2334. doi: 10.1007/s00192-022-05126-4. Epub 2022 Mar 2.
4
Patient-reported outcomes and outcome measures in childbirth perineal trauma research: a systematic review.产妇分娩会阴创伤研究中的患者报告结局和结局测量指标:系统评价。
Int Urogynecol J. 2021 Jul;32(7):1695-1706. doi: 10.1007/s00192-021-04820-z. Epub 2021 Jun 18.
5
Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews.保守干预治疗女性尿失禁:Cochrane 系统综述概述。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD012337. doi: 10.1002/14651858.CD012337.pub2.
6
Acupuncture for treating overactive bladder in adults.针刺治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2.
7
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
8
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Outcome reporting in trials on conservative interventions for pelvic organ prolapse: A systematic review for the development of a core outcome set.针对盆腔器官脱垂的保守干预措施的试验中的结局报告:制定核心结局集的系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Jan;268:100-109. doi: 10.1016/j.ejogrb.2021.08.028. Epub 2021 Aug 28.

引用本文的文献

1
Female urethral stricture disease: a narrative review on diagnosis, surgical techniques and outcomes.女性尿道狭窄疾病:关于诊断、手术技术及预后的叙述性综述
Int J Impot Res. 2025 May 10. doi: 10.1038/s41443-025-01079-6.
2
Three-year patient-reported outcomes of single-incision versus transobturator slings for female stress urinary incontinence are equivalent.经单切口与经闭孔吊带治疗女性压力性尿失禁的 3 年患者报告结局相当。
Int Urogynecol J. 2023 Sep;34(9):2265-2274. doi: 10.1007/s00192-023-05538-w. Epub 2023 Apr 26.